Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College ...

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with ...

WASHINGTON, September 29, 2024 — A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering ...

Meningiomas are the most frequent primary intracranial tumours in adults, exhibiting a spectrum from benign to highly aggressive phenotypes. Diagnosis typically begins with neuroimaging, principally ...

For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...

In a cohort study, childhood cancer survivors had an elevated lifetime risk for meningioma (35-year cumulative incidence, 2.3%). High-dose cranial radiation therapy, younger age at diagnosis, female ...

Who they affect: Meningiomas are more common in older adults, especially women, with studies showing a 2.7% prevalence among 70-year-old women. When to act: Small, slow-growing tumors may only require ...

Brain tumor symptoms a Mayo Clinic doctor monitors in her own body include headaches, fatigue, nausea or vomiting and ...

Depo-Provera, a commonly used injectable contraceptive, has been linked to an increased risk of meningiomas, which are a type of brain tumor. If you or someone you know has been diagnosed with a ...

Integrating multiple molecular profiling approaches of meningioma, the most common primary brain tumor, could transform patient care by providing a better prognosis and revealing the tumors that ...